Quantcast
Ennis & Ennis, P.A. | Personal Injury Attorney
1.800.856.6405

Vaginal Mesh Sling

Vaginal Mesh Sling Recall Lawsuit Attorney News Archive

Bookmark and Share 

Transvaginal mesh litigation continue to move forward as depositions of top executives from Ethicon and Johnson & Johnson progress, reports Ennis & Ennis, PA
- Ennis & Ennis
09/26/2012 - Litigation involving the nationwide claims of women adversely affected by transvaginal mesh devices continues to move forward. Chief Judge Joseph R. Goodwin who is overseeing the MDL cases has recently scheduled a second set of bellwether cases for June 24, 2013. An MDL was created to consolidate vaginal mesh lawsuits against manufacturers, C.R. Bard, American Medical Systems (AMS), Boston Scientific, Ethicon/Gynecare and most recently Coloplast.
READ MORE::

Ennis & Ennis, P.A. Supports Public Citizen's Petition to Recall Transvaginal Mesh Devices
- Ennis & Ennis
08/30/2011 - Ennis & Ennis, P.A. strongly supports consumer advocacy group's, Public Citizen, petition dated August 25, 2011 to the U.S. Food and Drug Administration (FDA) urging a recall of transvaginal mesh devices. The petition requests a ban on the marketing of the mesh products, an order to all manufacturers to recall the products, and a requirement that all future transvaginal mesh devices be classified as Class III devices.
READ MORE::

FDA Recalls Pinnacle Pelvic Floor Repair Kit
- Ennis & Ennis
08/26/2011 - According to Ennis & Ennis, P.A., on August 3, 2011 the US Food and Drug Administration (FDA) recalled the Pinnacle Pelvic Floor Repair Kit manufactured by Boston Scientific Corporation (BSC). The Pinnacle device is made of the synthetic material, polypropylene, and is implanted transvaginally to treat pelvic organ prolapse (POP) stress urinary incontinence (SUI).
READ MORE::

Medical Products Manufacturer Medline Faces Claims of Providing Counterfeit Surgical Mesh
- Ennis & Ennis
08/22/2012 - On August 6, 2012 the U.S. Judicial Panel on Multidistrict Litigation (JPMDL) consolidated all Coloplast federal transvaginal mesh cases into one court in the Southern District of West Virginia before the Honorable Joseph R. Goodwin.
READ MORE::

Medical Products Manufacturer Medline Faces Claims of Providing Counterfeit Surgical Mesh
- Ennis & Ennis
08/02/2012 - Claims of negligence and fraudulent marketing are being brought against Medline for selling counterfeit surgical mesh popularly used in hernia repairs. [1] So far 18 claims have been made where patients received the counterfeit product and had complications according to the Chicago Business Journal.
READ MORE::

$5.5 Million Awarded to Transvaginal Mesh Victim
- Ennis & Ennis
07/30/2012 - A jury awarded a woman $5.5 million against C.R. Bard for serious injuries sustained by a transvaginal mesh device. This was the first transvaginal mesh claim to go to trial, however there are currently hundreds of other similar cases currently pending against multiple manufacturers, including C.R. Bard, American Medical Systems, Johnson & Johnson’s Ethicon and Boston Scientific, involving polypropylene mesh used to treat pelvic organ prolapse and stress urinary incontinence.
READ MORE::

Johnson & Johnson Violated FDA Order to Halt Sales of Transvaginal Mesh
- Ennis & Ennis, P.A.
06/27/2012 - In complete disregard of an order by the U.S. Food and Drug Administration (FDA) to stop marketing the Gynecare Prolift vaginal mesh implant, Johnson and Johnson (J&J) continued to sell the product for nine additional months.  According to court records, in a letter dated August 24, 2007, the FDA advised J&J to halt the sales of the Gynecare Prolift vaginal mesh until such time the agency determined whether the device was the “substantially equivalent” to other mesh products on the market.
READ MORE::

Johnson and Johnson Finally Offers to Cease the Sales of Vaginal Mesh Implants
- Ennis & Ennis, P.A.
06/05/2012 - On June 4, 2012, Johnson and Johnson’s Ethicon unit offered to terminate the sales of four vaginal mesh devices that are the subject of potentially thousands of lawsuits files by women who allege the devices caused serious injuries.  These devices are used to treat pelvic organ prolapse and stress urinary incontinence.
READ MORE::

First Federal Bard Transvaginal Mesh Lawsuit Scheduled for Trial in February 2013
- Ennis & Ennis
05/04/2012 - On May 1, 2012, U. S. District Judge Joseph R. Goodwin, the presiding judge for all federal transvaginal mesh lawsuits against C.R. Bard Inc., issued an Order scheduling the first bellwether trial in MDL 2187 to begin February 5, 2013.
READ MORE::

Vaginal Mesh Device Sold in the US Without FDA Approval
- Ennis & Ennis
04/11/2012 - Bloomberg News reported that Johnson & Johnson marketed the Gynecare Prolift mesh device in March 2005, touting it as an “innovative and effective surgical option” for weakened pelvic muscles. However, the U.S. Food and Drug Administration (FDA) did not clear the Gynecare Prolift mesh until May 2008, after Johnson and Johnson sought approval for a related product.
READ MORE::

Vaginal Mesh Lawsuits Consolidated and Transferred Before One Judge
Ennis & Ennis, P.A. Reports of Consolidation and Transfer of Transvaginal Mesh Lawsuits to West Virginia District Court
- Ennis & Ennis
02/13/2012 - Ennis & Ennis, P.A. reports that the U.S. Judicial Panel on Multidistrict Litigation (JPML) issued an Order to consolidate and transfer three vaginal mesh multidistrict litigations (MDLs) into a single proceeding before Chief Judge Joseph R. Goodwin in the U.S. District Court Southern District of West Virginia.
READ MORE::

House Democrats Call for Safety Hearings on Lap Bands and Transvaginal Mesh:
Ennis & Ennis, P.A. Supports the House Democrat’s Position in Questioning Whether FDA Medical Device Approval Process Protects the Public
- Ennis & Ennis
02/02/2012 - House Democrats from the Energy and Commerce Committee, led by Representative Henry Waxman of California, urged Republicans to hold hearings to examine Lap-Band weight loss devices and transvaginal mesh devices, which have developed serious defects after being implanted.
READ MORE::

FDA Requires Transvaginal Mesh Makers to Study Risks:
Ennis & Ennis, P.A. explains the FDA’s Order to manufacturers of transvaginal mesh devices requiring safety studies to be conducted on the devices used to treat pelvic organ prolapse and stress urinary incontinence.

- Ennis & Ennis
01/09/2012 - On January 3, 2012, the U.S. Food and Drug Administration (FDA) mandated postmarket surveillance studies be performed by manufacturers of urogynecologic surgical mesh devices. The FDA issued 88 postmarket study orders to 33 manufacturers of transvaginal mesh for pelvic organ prolapse (POP) and 11 postmarket study orders to seven manufacturers of mesh mini-slings for stress urinary incontinence (SUI). “These are studies that should have been conducted before the devices were approved by the FDA,” commented attorney Holly Ennis of Ennis & Ennis, P.A.
READ MORE::

Vaginal Mesh Lawsuits Scheduled For Trial
- Ennis & Ennis
01/03/2012 - The first Ethicon Gynecare vaginal mesh lawsuits are scheduled to go to trial before a jury in New Jersey state court in November of 2012.. Judge Carol E. Higbee is overseeing the litigation where more than 350 lawsuits over Ethicon Gynecare transvaginal mesh have been centralized for pretrial proceedings.
READ MORE::

ObGyn and Urogynecologic Societies Issue Joint Opinion on Transvaginal Mesh
- Ennis & Ennis
12/092011 - On November 21, 2011, the American College of Obstetricians and Gynecologists (The College) and the American Urogynecologic Society (AUGS) issued a Joint Committee Opinion opining that due to the concerns about the safety and efficacy of the use of transvaginal mesh to treat pelvic organ prolapse (POP), it should be reserved for high-risk women for whom the benefit may justify the risk.
READ MORE::

Plaintiffs with C.R. Bard Mesh Device Claims May be Added to Avaulta MDL
- Ennislaw
09/20/2011 - Twenty-nine plaintiffs with claims arising from the implantation of a C.R. Bard pelvic mesh device have requested that the Judicial Panel on the Multidistrict Litigation (MDL) expand the scope of the Bard Avaulta MDL to include their cases.
READ MORE::

Notify FDA of Adverse Events with Medications and Medical Devices
- Ennislaw
09/19/2011 - In a world of endless technology, there are so many unused informational resources for patients. According to Ennis & Ennis, P.A. one of the single most helpful resources for patients is the U.S. Food and Drug Administration (FDA) website. In addition to having the ability to research data on drugs and medical devices, the FDA website also allows a consumer to easily report adverse events experienced with FDA-regulated drugs, medical devices, nutritional products and cosmetics.
READ MORE::

FDA May Classify Surgical Mesh Devices for Failing Organs as High Risk
- Ennislaw
09/01/2011 - Johnson & Johnson, Boston Scientific Corp. (BSX) and other makers of surgical mesh may have to submit added safety data to regulators to keep their products on the market under a Food and Drug Administration staff recommendation.
READ MORE::

Ennis & Ennis, P.A. Explains the Purpose of the Upcoming FDA Advisory Meeting for Transvaginal Mesh
- Ennislaw
08/17/2011 - With a significant increase in the amount of complaints associated with the surgical placement of mesh through the vagina to repair pelvic organ prolapse (POP), the US Food and Drug Administration (FDA) will convene a meeting of the Obstetrics-Gynecology Devices Panel of the Medical Devices Advisory Committee on September 8-9, 2011. Ennis and Ennis, P.A. reports that the purpose of the meeting is to consider regulatory changes that may improve the understanding and effectiveness of the devices. Some of the regulatory changes being considered include:
READ MORE::

FDA’s Recommendations to Women Considering Pelvic Organ Prolapse Surgery
- Ennislaw
08/11/2011 - Last month the U.S. Food and Drug Administration (FDA) updated a Safety Communication, warning of the dangers associated with the surgical placement of mesh through the vagina to repair pelvic organ prolapse (POP). According to Ennis & Ennis, P.A., this update follows a recent significant increase in the number of adverse events reported to the FDA. For women who are considering surgery for pelvic organ prolapse, it is important to know that within this updated Safety Communication, the FDA makes the following recommendations:
READ MORE::

FDA’s Transvaginal Mesh Device Recommendations to Health Care Providers

- Ennislaw
08/08/2011 - On July 13, the U.S. Food and Drug Administration (FDA) updated an advisory on vaginal mesh implants reporting that there is little evidence that the implants improve pelvic organ prolapse and that patients are exposed to a number of risks and complications, which are not rare. According to Ennis & Ennis, P.A., the FDA then issued a Safety Communication, which provided an Overview, a Summary of Adverse Event Reports, a Review of their Literature, a Summary of their Key Findings and Recommendations with regards to these transvaginal mesh devices.
READ MORE::

FDA Issues Post Operative Recommendations for Women with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse
- Ennislaw
08/04/2011 - On July 13, the U.S. Food and Drug Administration (FDA) updated an advisory on vaginal mesh implants reporting that there is little evidence that the implants improve pelvic organ prolapse and that patients are exposed to a number of risks and complications, which are not rare. According to Ennis & Ennis, P.A., the FDA then issued a Safety Communication, which provided an Overview, a Summary of Adverse Event Reports, a Review of their Literature, a Summary of their Key Findings and Recommendations with regards to these transvaginal mesh devices.
READ MORE::

FDA Issues Safety Communication Update On Serious Complications Associated With Transvaginal Placement Of Surgical Mesh For Pelvic Organ Prolapse.
- Ennislaw
07/20/2011 - The L.A. Times reported on July 13, 2011 the FDA released an updated advisory on serious complications associated with Transvaginal placement of surgical mesh for pelvic organ prolapse. The FDA has scheduled a meeting for a panel of outside experts for recommendations on how to proceed on September 8-9, 2011.

READ MORE::

If you or a loved one have suffered or been injured from a defective transvaginal mesh sling you may be entitled to compensation. Contact the vaginal mesh sling attorneys of Ennis & Ennis today for a free confidential case evaluation. Our on staff nurse and lawyers are standing by to answer any questions you may have regarding your transvaginal mesh sling injury a possible class action lawsuit, or any other type of vaginal mesh litigation. Call us toll-free at: 1.800.856.6405 or fill out the free case evaluation form on this page.

Bard Avaulta Transvaginal Mesh Implant Lawsuit Information::

Gynecare Prolift Pelvic Floor Repair System Lawsuit Information::

Offices:
Washington DC Office
1101 Pennsylvania Ave.
Suite 600
Washington, DC 20004
Telephone: 202.756.2972
Miami Office
1111 Brickell Avenue
11th Floor
Miami, FL 33131
Telephone: 305.913.7199
Fort Lauderdale Office
110 E. Broward Blvd.
Suite 1700
Fort Lauderdale, FL 33301
Telephone: 954.315.3934
Facsimile: 954.315.3914


Required fields in Red:
 
Name:
Email:
 
Telephone:
(123-123-1234)
 
Mailing Address:
 
City:
 
State:
 
Zip Code:
Please List The Drug, Medical Device or Defective Product You Are Inquiring About:
Please List Any Side Effects, Injuries, or Property Damage:
Additional Information:
 
 
1.800.856.6405
©2010 Ennis & Ennis, P.A. All rights reserved.